Article info

Download PDFPDF

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema

Authors

  • Elisa E Cornish Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia Department of Ophthalmology, Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kelvin YC Teo Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia Department of Ophthalmology, Singapore National Eye Centre, Singapore PubMed articlesGoogle scholar articles
  • Mark C Gillies Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia Department of Ophthalmology, Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Lyndell L Lim Department of Ophthalmology, Centre for Eye Research Australia Ltd, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Vuong Nguyen Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sanjeewa Wickremasinghe Department of Ophthalmology, Centre for Eye Research Australia Ltd, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Hemal Mehta Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia Ophthalmology Department, Royal Free London NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Ian L McAllister University of Western Australia, Lions Eye Institute, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Samantha Fraser-Bell Department of Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia Department of Ophthalmology, Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Elisa E Cornish, The University of Sydney Save Sight Institute, Sydney, NSW 2000, Australia; elisa.cornish{at}sydney.edu.au
View Full Text

Citation

Cornish EE, Teo KY, Gillies MC, et al
Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema

Publication history

  • Received June 9, 2021
  • Accepted July 14, 2021
  • First published August 2, 2021.
Online issue publication 
December 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.